Cargando…

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing

Adoptive cellular therapies with T cells are increasingly used to treat a variety of conditions. For instance, in a recent phase 1/2 trial, we prophylactically administered multivirus-specific T-cell products to protect recipients of T-cell–depleted allogeneic stem cell grafts against viral reactiva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huisman, W., Roex, M. C. J., Hageman, L., Koster, E. A. S., Veld, S. A. J., Hoogstraten, C., van Balen, P., van Egmond, H. M., van Bergen, C. A. M., Einsele, H., Germeroth, L., Amsen, D., Falkenburg, J. H. F., Jedema, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996373/ https://www.ncbi.nlm.nih.gov/pubmed/36121440 http://dx.doi.org/10.1182/bloodadvances.2022007270

Ejemplares similares

Amino acids at position 5 in the peptide/MHC binding region of a public virus‐specific TCR are completely inter‐changeable without loss of function
por: Huisman, Wesley, et al.
Publicado: (2022)

Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
por: Huisman, Wesley, et al.
Publicado: (2022)

Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction
por: Huisman, Wesley, et al.
Publicado: (2021)

The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells
por: Laghmouchi, Aicha, et al.
Publicado: (2019)

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )
por: Huisman, Wesley, et al.
Publicado: (2020)

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
por: van Balen, Peter, et al.
Publicado: (2018)

Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
por: Laghmouchi, Aicha, et al.
Publicado: (2022)

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
por: van Balen, Peter, et al.
Publicado: (2020)

Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
por: Laghmouchi, Aicha, et al.
Publicado: (2020)

Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression
por: Loeff, Floris C., et al.
Publicado: (2018)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer
por: Jahn, Lorenz, et al.
Publicado: (2016)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
por: Griffioen, Marieke, et al.
Publicado: (2016)

Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells
por: van Loenen, Marleen M., et al.
Publicado: (2013)

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
por: Wachsmann, Tassilo L. A., et al.
Publicado: (2022)

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
por: Meeuwsen, Miranda H., et al.
Publicado: (2023)

Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder
por: Claushuis, Theodora A.M., et al.
Publicado: (2022)

Pitfalls in TCR gene clonality testing: teaching cases
por: Groenen, Patricia J. T. A., et al.
Publicado: (2008)

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
por: Rohaan, M.W., et al.
Publicado: (2022)

QTL mapping in diploid potato by using selfed progenies of the cross S. tuberosum × S. chacoense
por: Meijer, D., et al.
Publicado: (2018)

Persistent biliary hypoxia and lack of regeneration are key mechanisms in the pathogenesis of posttransplant nonanastomotic strictures
por: de Jong, Iris E. M., et al.
Publicado: (2021)

A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells
por: Luimstra, Jolien J., et al.
Publicado: (2018)

Posttransplant Metabolic Syndrome
por: Siddiqui, M. Shadab, et al.
Publicado: (2012)

Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies
por: Jahn, Lorenz, et al.
Publicado: (2016)

Posttransplant Complications and Comorbidities
por: Danziger-Isakov, Lara, et al.
Publicado: (2018)

Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?
por: van Bergen, Cornelis A. M., et al.
Publicado: (2014)

Human T cells recognize HLA-DP–bound peptides in two orientations
por: Klobuch, Sebastian, et al.
Publicado: (2022)

Posttransplant infections
por: Thomas, Beje, et al.
Publicado: (2019)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
por: Wachsmann, Tassilo L. A., et al.
Publicado: (2023)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: van der Lee, Dyantha I., et al.
Publicado: (2021)

Tumour-incidence in progeny of thalidomide-treated mice.
por: Roe, F. J., et al.
Publicado: (1967)

Posttransplant lymphoproliferative disease presenting as jejunal perforation
por: Krishna, K. C., et al.
Publicado: (2009)

Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome
por: Tepel, Martin, et al.
Publicado: (2022)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020)

Posttransplant Intrarenal Lymphangiectasia
por: Kord, Ali, et al.
Publicado: (2020)

Profiling proliferative cells and their progeny in damaged murine hearts
por: Kretzschmar, Kai, et al.
Publicado: (2018)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ep7eh67q02dbfqbfg50kefo62u